Healthcare Research Network - Chicago is an elite Clinical Research Site Network comprised of private physicians from multiple specialties that conduct clinical research studies. Our focus is in Phase IIB – Phase IV clinical research. Our concentration is in prevalent chronic conditions. We were founded in 1998 and have successfully completed over 1000 trials. Our randomization to contractual commitment ration is 108% over the last 5 years.
Our therapeutic focus and research experience includes the following:
• Chronic Pain
• Osteoarthritis
• Rheumatology (RA, Gout)
• Endocrinology (Diabetes and Metabolic Disorders)
• Asthma/Allergy
• Pulmonary Diseases
• Gastrointestinal (IBS, Ulcerative Colitis, Crohn's Disease)
• Oncology
• Hematology
• Neurological Disorder
• Vaccine
Phase III study to evaluate the efficacy of study drug in chronic pain patients.
Phase III study to evaluate the efficacy of study drug in Rheumatoid Arthritis patients.
Phase III study to evaluate the efficacy of study drug in Irritable Bowel Syndrome patients.
Phase III study to evaluate the efficacy of study drug in Over-Active Bladder patients.
Phase III study to evaluate the efficacy of study drug in Opioid Induced Constipation patients.
Phase II study to evaluate the efficacy of study drug in Osteoarthritis of the Knee patients.
Phase II study to evaluate the efficacy of study drug in Osteoarthritis of the Hip and/or Knee patients.
Phase III study to evaluate the efficacy of study drug in Diabetic Peripheral Neuropathy patients.
Phase III study to evaluate the efficacy of study drug in Diabetes Type II patients.
Phase III study to evaluate the efficacy of study drug in Gout patients.
Phase III study to evaluate the efficacy of study drug in Chronic Low-Back Pain patients.
Phase II study to evaluate the efficacy of study drug in Sciatica patients.
Phase III study to evaluate the efficacy of study drug in Shingles patients.
Site Director
